Settlement Objections Rise: Lawyers Found the Loopholes

The $7.25 billion Roundup settlement looked bulletproof until 100 class members decided to read the fine print. Now they're filing objections that sound like law school exams gone wrong.

This is what happens when lawyers get paid to find problems with other lawyers' work. The Roundup deal — designed to end thousands of lawsuits over alleged cancer links to Bayer's weedkiller — faces final approval on July 9. But the objectors aren't impressed with the math.

Here's the thing about mass tort settlements: they're not contracts between equals. They're negotiations between giants who want the problem to disappear and plaintiffs who want compensation before they die. The lawyers on both sides have incentives that don't always align with their clients' best interests.

The objectors found what they always find: the settlement gives too much to the lawyers and too little to the victims. The payout structure favors future claimants over current ones. The release language is broader than the Grand Canyon. The administrative costs will eat chunks of the fund before anyone sees a check.

This is standard. What's not standard is having 100 people organized enough to file formal objections. Most class members never read the settlement notice. They trust their lawyers to negotiate something reasonable and mail them a check eventually. These objectors read every footnote.

They're using a weapon most people don't know exists: the fairness hearing. Federal judges must approve class action settlements, and they're supposed to ensure the deal is "fair, reasonable, and adequate" — legal language that means what it sounds like it means.

The objectors will stand up in court and explain exactly why this settlement is none of those things. They'll point to better deals in similar cases. They'll question the lawyers' fee calculations. They'll ask why Bayer gets such broad protection from future lawsuits when the science is still developing.

Bayer wants this over. The company has faced over 100,000 Roundup lawsuits since 2018, when a jury awarded $289 million to a groundskeeper who claimed the product caused his cancer. Three subsequent trials resulted in massive verdicts before Bayer agreed to settle most pending cases for $10 billion in 2020.

But settlements create their own problems. The bigger the pot, the more people want a piece. The broader the release, the more objections it generates. And the longer the approval process takes, the more time plaintiffs have to organize and complain.

The real issue isn't money — it's power. Who gets to decide what constitutes fair compensation for cancer allegedly caused by corporate negligence? The lawyers who negotiated the deal? The judge who must approve it? Or the victims who have to live with both the disease and the settlement terms?

Your move tomorrow: If you're part of any class action settlement, you have 30-60 days to object or opt out after receiving notice. Most people ignore these mailings. Don't. Read them. The deadline isn't a suggestion — it's the last moment you have any say in what happens to your claim.